Personalized Medicine and Imaging Serum Interleukin-8 Re fl ects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients.

  2014cited by this paper
• Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma

  2014cited by this paper
• Interleukin-8 and Interleukin-17 for Cancer

  2014cited by this paper
• Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer

  2013cited by this paper
• Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma

  2013cited by this paper
• Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

  2013cited by this paper
• Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.

  2013cited by this paper
• BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

  2013cited by this paper
• An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma

  2012cited by this paper
• Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts Survival

  2012cited by this paper
• Interleukin-8, a promising predictor for prognosis of pancreatic cancer.

  2012cited by this paper
• Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.

  2012influential reference
• Baseline Plasma Levels of Interleukin-8 in Stage IV Non-Small-Cell Lung Cancer Patients: Relationship With Nutritional Status and Prognosis

  2012cited by this paper
• Interleukin-8 (CXCL8) in Tumor Associated Non-Vascular Extracellular Fluids: Its Diagnostic and Prognostic Values. A Review

  2012cited by this paper
• Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide

  2012cited by this paper
• Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity.

  2011cited by this paper
• Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation

  2011cited by this paper
• Cancer‐promoting tumor‐associated macrophages: New vistas and open questions

  2011cited by this paper
• Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

  2009cited by this paper
• Cytokine and growth factor responses after radiotherapy for localized ependymoma.

  2009cited by this paper
• Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.

  2009cited by this paper
• Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

  2009cited by this paper
• The Interleukin-8 Pathway in Cancer

  2008influential reference
• Correlation of serum IL‐6, IL‐8 and IL‐10 levels with clinicopathological features and prognosis in patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas--implication for clinical evaluation of cancer patient.

  2008cited by this paper
• Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Serum Vascular Endothelial Growth Factor (VEGF) and Interleukin-8 (IL-8) Levels in Small Cell Lung Cancer

  2006cited by this paper
• Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma

  2006cited by this paper
• The role of interleukin-8 in cancer cells and microenvironment interaction.

  2005cited by this paper
• [The value of plasma interleukin-6 and interleukin-8 in monitoring of patients with breast cancer].

  2005cited by this paper
• Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma

  2005cited by this paper
• Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival

  2004cited by this paper
• Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.

  2004cited by this paper
• The role of circulating IL‐8 and VEGF protein in the progression of gastric cancer

  2003cited by this paper
• Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.

  2003cited by this paper
• Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma.

  2003cited by this paper
• Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis

  2003cited by this paper
• Multiple control of interleukin‐8 gene expression

  2002cited by this paper
• Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosis

  2002cited by this paper
• Elevated Serum Levels of Interleukin-8 in Advanced Non-Small Cell Lung Cancer Patients: Relationship with Prognosis

  2002cited by this paper
• Interleukin-8 and human cancer biology.

  2001cited by this paper
• Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

  2000cited by this paper
• Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.

  2000cited by this paper
• Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

  1999cited by this paper
• Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer.

  1999cited by this paper
• Regulation of Interleukin-8 Gene Expression

  1999cited by this paper
• The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?

  1998cited by this paper
• Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression.

  1997cited by this paper
• Serum interleukin‐8 (IL‐8) is elevated in patients with metastatic melanoma and correlates with tumour load

  1995cited by this paper
• Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis

  1994cited by this paper
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

  1994cited by this paper
• Essential involvement of interleukin‐8 (IL‐8) in acute inflammation

  1994cited by this paper
• IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

  1993cited by this paper
• Tumor-associated macrophages.

  1989cited by this paper
• Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

  1989cited by this paper
• Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.

  1987cited by this paper

• No citing papers are available for this paper.